Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Biochem Pharmacol. 2014 May 20;90(3):297–306. doi: 10.1016/j.bcp.2014.05.008

Fig. 1.

Fig. 1

Chemical structures of representative agonists used in the present study. Non-nucleoside agonists: BAY and LUF5833; 5′-substituted: NECA, CPCA, 2-substituted: MRS3997 and MRS3534. N6-substituted: MRS5911.